Search - tctmd.com

Displaying 261 - 280 of 333

Sort: Relevancy | Date

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Yael L. Maxwell

March 30, 2016

News Daily News

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Yael L. Maxwell

March 30, 2016

News Daily News

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Yael L. Maxwell

March 30, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

News Daily News

覆膜支架在治疗罕见先天性主动脉病症患者方面前景良好：COAST II

L.A. McKeown

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

L.A. McKeown

February 21, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

Advertisement

Optimal Duration of DAPT: Update on DAPT Guidelines

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

覆膜支架在治疗罕见先天性主动脉病症患者方面前景良好：COAST II

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content